Literature DB >> 20810402

Femoral profunda artery aneurysm as an unusual first presentation of Behcet disease.

Elizabeth A O'Leary1, Iraj Sabahi, John J Ricotta, Brian Walitt, Cameron M Akbari.   

Abstract

Behcet disease is a multisystem inflammatory disorder, rarely found in African Americans. Arterial involvement occurs in less than 8% of patients. Profunda femoral artery aneurysms (PFAAs) are extremely rare and often occur with synchronous aneurysms. We present a case of an African American man diagnosed with Behcet disease from his presentation with PFAA. He was also found to have a synchronous hypogastric artery aneurysm. The patient was immediately treated with corticosteroids and infliximab to control systemic and vascular inflammation, returning 1 month later for surgery. He had a repair of the left PFAA with a common femoral to profunda femoris artery bypass with reversed saphenous vein graft and aneurysmorrhaphy. When a patient presents with an aneurysm in an unusual location, it is important to evaluate for other aneurysms. A careful history and physical examination is also required to see if the aneurysm may be part of an underlying systemic syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810402     DOI: 10.1177/1538574410379655

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  3 in total

1.  Behcet's disease with aneurysm of internal iliac artery and percutaneous treatment.

Authors:  Mehmet Erdem Memetoglu; Asim Kalkan
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-06

2.  Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.

Authors:  M B Owlia; G Mehrpoor
Journal:  ISRN Pharmacol       Date:  2012-03-08

Review 3.  Endovascular Treatment of Behcet Disease With Recurrent Infrainguinal Arterial Pseudoaneurysms: A Case Report and Literature Review.

Authors:  Ze-Yang Ding; Guan-Nan Jin; Xi Ai; Li-Yan Li; Ping Zheng; Yan Guan; Qi Wang; Zhi-Wei Zhang; Jun Yang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.